BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 12872134)

  • 1. Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.
    Takaoka A; Hayakawa S; Yanai H; Stoiber D; Negishi H; Kikuchi H; Sasaki S; Imai K; Shibue T; Honda K; Taniguchi T
    Nature; 2003 Jul; 424(6948):516-23. PubMed ID: 12872134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired alpha-interferon signaling in transitional cell carcinoma: lack of p48 expression in 5637 cells.
    Matin SF; Rackley RR; Sadhukhan PC; Kim MS; Novick AC; Bandyopadhyay SK
    Cancer Res; 2001 Mar; 61(5):2261-6. PubMed ID: 11280796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive IFN-alpha/beta signal for efficient IFN-alpha/beta gene induction by virus.
    Hata N; Sato M; Takaoka A; Asagiri M; Tanaka N; Taniguchi T
    Biochem Biophys Res Commun; 2001 Jul; 285(2):518-25. PubMed ID: 11444873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the transcription factor ISGF3 by interferon-gamma.
    Matsumoto M; Tanaka N; Harada H; Kimura T; Yokochi T; Kitagawa M; Schindler C; Taniguchi T
    Biol Chem; 1999 Jun; 380(6):699-703. PubMed ID: 10430035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression.
    Zhang HM; Yuan J; Cheung P; Chau D; Wong BW; McManus BM; Yang D
    Mol Cell Biol; 2005 Jul; 25(14):6247-58. PubMed ID: 15988033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Jak-STAT pathway stimulated by interferon alpha or interferon beta.
    Horvath CM
    Sci STKE; 2004 Nov; 2004(260):tr10. PubMed ID: 15561979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boosting p53 with interferon and viruses.
    Vilcek J
    Nat Immunol; 2003 Sep; 4(9):825-6. PubMed ID: 12942081
    [No Abstract]   [Full Text] [Related]  

  • 8. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
    Phan RT; Dalla-Favera R
    Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The POU transcription factor Oct-1 represses virus-induced interferon A gene expression.
    Mesplède T; Island ML; Christeff N; Petek F; Doly J; Navarro S
    Mol Cell Biol; 2005 Oct; 25(19):8717-31. PubMed ID: 16166650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IRF-7 is the master regulator of type-I interferon-dependent immune responses.
    Honda K; Yanai H; Negishi H; Asagiri M; Sato M; Mizutani T; Shimada N; Ohba Y; Takaoka A; Yoshida N; Taniguchi T
    Nature; 2005 Apr; 434(7034):772-7. PubMed ID: 15800576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knock down of p53 levels in human keratinocytes increases susceptibility to type I and type II interferon-induced apoptosis mediated by a TRAIL dependent pathway.
    Chaturvedi V; Bodner B; Qin JZ; Nickoloff BJ
    J Dermatol Sci; 2006 Jan; 41(1):31-41. PubMed ID: 16289694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Tcf-4 as a transcriptional target of p53 signalling.
    Rother K; Johne C; Spiesbach K; Haugwitz U; Tschöp K; Wasner M; Klein-Hitpass L; Möröy T; Mössner J; Engeland K
    Oncogene; 2004 Apr; 23(19):3376-84. PubMed ID: 14990988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different tumoricidal effects of interferon subclasses and p53 status on hepatocellular carcinoma development and neovascularization.
    Noguchi R; Yoshiji H; Ikenaka Y; Kitade M; Kaji K; Yoshi J; Yanase K; Namisaki T; Yamazaki M; Tsujimoto T; Akahane T; Uemura M; Fukui H
    Int J Oncol; 2008 Jan; 32(1):193-9. PubMed ID: 18097559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of gene expression profile in rat Kupffer cells stimulated with IFN-alpha or IFN-gamma.
    Zocco MA; Carloni E; Pescatori M; Saulnier N; Lupascu A; Nista EC; Novi M; Candelli M; Cimica V; Mihm S; Gasbarrini G; Ramadori G; Gasbarrini A
    Dig Liver Dis; 2006 Aug; 38(8):563-77. PubMed ID: 16807150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells.
    Buttmann M; Berberich-Siebelt F; Serfling E; Rieckmann P
    J Vasc Res; 2007; 44(1):51-60. PubMed ID: 17167270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interferon-stimulated gene factor 3 complex mediates the inhibitory effect of interferon-beta on matrix metalloproteinase-9 expression.
    Zhao X; Nozell S; Ma Z; Benveniste EN
    FEBS J; 2007 Dec; 274(24):6456-68. PubMed ID: 18028425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the effects of interferon a on several human hepatoma cell lines: analysis of the signalling pathway of the cytokine and of its effects on apoptosis and cell proliferation.
    Legrand A; Vadrot N; Lardeux B; Bringuier AF; Guillot R; Feldmann G
    Liver Int; 2004 Apr; 24(2):149-60. PubMed ID: 15078480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic inhibition of pseudorabies virus replication by porcine alpha/beta interferon and gamma interferon in vitro.
    Yao Q; Qian P; Cao Y; He Y; Si Y; Xu Z; Chen H
    Eur Cytokine Netw; 2007 Jun; 18(2):71-7. PubMed ID: 17594939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional activation of p53 by Pitx1.
    Liu DX; Lobie PE
    Cell Death Differ; 2007 Nov; 14(11):1893-907. PubMed ID: 17762884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses.
    Fink K; Lang KS; Manjarrez-Orduno N; Junt T; Senn BM; Holdener M; Akira S; Zinkernagel RM; Hengartner H
    Eur J Immunol; 2006 Aug; 36(8):2094-105. PubMed ID: 16810635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.